Cargando…

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients

This study aimed to evaluate the long-term efficacy and safety of a generic tacrolimus (Tacrobell [TCB]) compared to the original tacrolimus (Prograf [PGF]) in kidney transplant recipients. In this retrospective observational study, we analyzed the data from 444 patients who took TCB as a first-line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Son, Seung Yeon, Jang, Hye Ryoun, Lee, Jung Eun, Yoo, Heejin, Kim, Kyunga, Park, Jae Berm, Kim, Sung Joo, Oh, Ha Young, Huh, Wooseong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238812/ https://www.ncbi.nlm.nih.gov/pubmed/28138224 http://dx.doi.org/10.2147/DDDT.S118154

Ejemplares similares

Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients
por: Choi, Ho Joong, et al.
Publicado: (2018)

Generic Tacrolimus (Tacrobell(®)) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2019)

A single-centre comparison of the clinical outcomes at 6 months of renal transplant recipients administered Adoport(®) or Prograf(®) preparations of tacrolimus
por: Connor, Andrew, et al.
Publicado: (2013)

Serial ImmuKnow assay in stable kidney transplant recipients
por: Moon, Hyung Hwan, et al.
Publicado: (2014)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Development of a novel linear model for predicting recipient’s post-transplant serum creatinine level after living donor kidney transplantation: A multicenter cross-validation study
por: Rhu, Jinsoo, et al.
Publicado: (2019)

Risk Prediction for Contrast-Induced Nephropathy in Cancer Patients Undergoing Computed Tomography under Preventive Measures
por: Jeon, Junseok, et al.
Publicado: (2019)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

Clinical relevance of postoperative proteinuria for prediction of early renal outcomes after kidney transplantation
por: Jun, Junseok, et al.
Publicado: (2022)

C3d-Positive Preformed DSAs Tend to Persist and Result in a Higher Risk of AMR after Kidney Transplants
por: Choi, Sooin, et al.
Publicado: (2020)

The impact of early and late acute rejection on graft survival in renal transplantation
por: Koo, Eun Hee, et al.
Publicado: (2015)

Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
por: Huh, Kyungmin, et al.
Publicado: (2013)

Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients
por: Baek, Hyunjeong, et al.
Publicado: (2014)

Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
por: Kim, Sang Jin, et al.
Publicado: (2020)

Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored
por: González, Fernando, et al.
Publicado: (2017)

Pre-Transplant Angiotensin II Type 1 Receptor Antibodies and Anti-Endothelial Cell Antibodies Predict Graft Function and Allograft Rejection in a Low-Risk Kidney Transplantation Setting
por: Yu, Shinae, et al.
Publicado: (2020)

Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients
por: Jung, Hee-Yeon, et al.
Publicado: (2020)

Early postoperative urinary MCP-1 as a potential biomarker predicting acute rejection in living donor kidney transplantation: a prospective cohort study
por: Jang, Hye Ryoun, et al.
Publicado: (2021)

Perioperative risk factors of progressive chronic kidney disease following liver transplantation: analyses of a 10-year follow-up single-center cohort
por: Lee, Kyungho, et al.
Publicado: (2020)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
por: Kim, Jong Man, et al.
Publicado: (2021)

Dual kidney transplantation offers a safe and effective way to use kidneys from deceased donors older than 70 years
por: Lee, Kyo Won, et al.
Publicado: (2020)

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
por: Alloway, Rita R., et al.
Publicado: (2017)

Recoverability of Diabetic Nephropathy of Donor Kidney After Kidney Transplantation
por: Lee, Kyo Won, et al.
Publicado: (2022)

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function
por: Han, Seung Seok, et al.
Publicado: (2016)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
por: Han, Seung Seok, et al.
Publicado: (2012)

Case Report of Kidney Paired Donation (KPD) with Desensitization: the Strategy and Experience of 3-Way KPD in Samsung Medical Center
por: Oh, Dongkyu, et al.
Publicado: (2018)

Flat Pattern Peaks of Tacrolimus Absorption and Associated Pharmacogenomic Variants in Kidney Transplantation Recipients
por: Kim, Suh Min, et al.
Publicado: (2022)

Epidermal Cysts in a Tacrolimus Treated Renal Transplant Recipient
por: Ahn, In Su, et al.
Publicado: (2011)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Reduced Tacrolimus Trough Level Is Reflected by Estimated Glomerular Filtration Rate (eGFR) Changes in Stable Renal Transplantation Recipients: Results of the OPTIMUM Phase 3 Randomized Controlled Study
por: Park, Sehoon, et al.
Publicado: (2018)

Recipient efficacy and safety of kidney transplantation from older living donor: consideration for using older kidney as a solution to the shortage of organs
por: Song, Ji Yeon, et al.
Publicado: (2021)

Depression is a main determinant of health-related quality of life in patients with diabetic kidney disease
por: Kim, Suhyun, et al.
Publicado: (2022)

The presence of simple renal cysts is associated with an increased risk of albuminuria in young adults
por: Boo, Hyo Jin, et al.
Publicado: (2022)

Predialysis predictors for identifying patients requiring dialysis at a higher glomerular filtration rate
por: Jeon, Junseok, et al.
Publicado: (2021)

Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan(®) and Mowel(®) after liver transplantation
por: Vollmar, Johanna, et al.
Publicado: (2015)

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
por: Jung, Jaewan, et al.
Publicado: (2021)

Clinical value of urinary cytokines/chemokines as prognostic markers in patients with crescentic glomerulonephritis
por: Jeon, Junseok, et al.
Publicado: (2022)

Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients
por: Lai, Elaine F., et al.
Publicado: (2022)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ereb45ck3tcmluf5svst4umurj